Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry aims to track and improve treatment for rare breast cancer

NCT ID NCT05964504

First seen Mar 21, 2026 · Last updated May 18, 2026 · Updated 7 times

Summary

This study is building a registry of people with metastatic lobular breast cancer, a less common type of breast cancer. Researchers will collect data from about 12 participants to create a new tool that better measures how well treatments are working. The goal is to improve survival by understanding this cancer better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Abramson Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • University of California, San Diego

    RECRUITING

    San Diego, California, 92053, United States

    Contact

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94122, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.